Gretchen Hong, NP
Adult Health · Dubuque, IANPI 1871733253
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations.
Across 17 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$64
- Otsuka America Pharmaceutical, Inc.$39
- Alkermes, Inc.$34
- Ironshore Pharmaceuticals Inc.$34
- AbbVie$26
- Takeda Pharmaceuticals U.S.A., Inc.$25
- plus $62 from 4 others
What the payments were for
- Food & beverage$283100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Alkermes, Inc. | 2 | $34 |
| Ironshore Pharmaceuticals Inc. | 2 | $34 |
| AbbVie | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Dexcom, Inc. | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Astellas Pharma US Inc | 1 | $11 |
How this compares
$283 in reported general payments places this provider in the 60th percentile of 77 adult health providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 13 | $12,095 |
| EliquisApixaban | 16 | $10,689 |
| Levothyroxine Sodium | 54 | $940 |
| Atorvastatin Calcium | 88 | $734 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $517 |
| Losartan Potassium | 46 | $462 |
| Omeprazole | 53 | $444 |
| Potassium Chloride | 23 | $424 |
| Celecoxib | 15 | $341 |
| Naproxen | 29 | $328 |
| Rosuvastatin Calcium | 24 | $302 |
| Metoprolol Succinate | 14 | $252 |
| Alendronate Sodium | 27 | $234 |
| Gabapentin | 22 | $223 |
| Pantoprazole Sodium | 17 | $192 |
Paid to pharmacies, not to this prescriber.
Other adult health in Dubuque
- Dori SevdeDubuque$1K
- Chelsey ZitelmanDubuque$307
- Lisa MeyerSioux City$8K
- Katie ShannonMason City$8K
- Barbara PetersonCedar Rapids$7K
- Eileen YeisleyIowa City$3K
- Suzanne HenningsIowa City$3K
- Jennifer BeckerIowa City$3K
- Amanda DavisOttumwa$2K
- Breanna TalbertCedar Rapids$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.